medac Pharma – the company
Metoject® is manufactured by medac GmbH, a privately owned Germany company founded in 1970 with its head office in Hamburg and its UK base in Stirling. medac specialises in the treatment of malignant diseases and has many years of experience as one of the leading manufacturers of both new and well proven therapeutic options in the specialist fields of autoimmune diseases, oncology, haematology, fibrinolysis and diagnostics.
As a company, medac strives to continuously improve scientific capabilities and drive forward innovative developments, to offer customers a comprehensive range of medications for a wide variety of diseases. medac also devotes attention to less common indications in an endeavour to develop therapeutic solutions and constantly expand the portfolio in line with market demands.